The role of medical department of pharmaceutical company in interaction with medical


Cite item

Full Text

Abstract

The actual condition of pharmaceutical industry in Russia is remarkable for high mutual need of medical community and pharmaceutical companies in cooperation. At that, the current alterations in the regulative legal area lead to increase of regulatory restrictions elated to interaction of personnel of companies and physicians. Against this background the medical department becomes an important section supporting mutually advantageous relationships with medical community. However, among physicians and personnel of pharmaceutical companies the clear-cut understanding of the role and mission of this department is still absent. The development of understanding of this kind both in companies and medical community can enhance effectiveness of functioning of medical department and make cooperation more prolific for both parties. The article proposes several directions concerning development of functioning of medical department. Among them - development of understandable system of effectiveness management, system of operational procedures and job description and analysis of expectations of medical community and commercial departments concerning cooperation of medical department.

About the authors

A. V Tolmachev

The Takeda Pharmaceuticals

Email: alexander.tdmachev@gmail.com
119048, Moscow, Russia

S. A Efimenko

The I.M. Sechenov first Moscow medical university of Minzdrav of Russia

119991, Moscow, Russia

References

  1. Широкова И. Бизнес обучает и информирует. Ремедиум. 2011; 5: 14-9.
  2. Garattini L., Gritti S., De Compadri P., Casadei G. Continuing medical education in six European countries: A comparative analysis. Hlth Policy. 2010; 94: 246-54.
  3. Федеральный закон от 21 ноября 2011 г. № 323-ФЗ "Об основах охраны здоровья граждан в Российской Федерации ". Date Views 11.09.2014 base.garant.ru/12191967/9/#ixzz3CzAsKJjS.
  4. Geba G. Principles and Practice of Pharmaceutical Medicine. Manhattan: John Wiley & Sons, Ltd; 2007.
  5. Baker D. The role of the medical science liaison in industry. AORN J. 2010; 91: 394-8.
  6. Optimizing the impact of the medical affairs function. Date Views 11.09.2014. www.campbellalliance.com/articles/Campbell_Alliance_Optimizmg_the_Impact_of_the_Medical_Affairs_Function.pdf.
  7. Medical Affairs Excellence: Structuring, Aligning and Funding for Global Success. Date Views 11.09.2014. www.best-in-class.com.
  8. Medical Affairs Reports. Date Views 11.09.2014. www.cuttingedgeinfo.com.
  9. Dumovic P., Chin J. Marketing masterclass medical science liaisons: A look to the future. J. Med. Market. Device, Diagn. Pharm. Market. 2008; 8: 193.
  10. Moss R., Black J. Health care professionals' expectations of the medical science liaison: A blinded survey. In: Therapeutic Innovation & Regulatory Science. 2013: 203-8.
  11. THE MSL CONNECTION. Date Views 11.09.2014. www.cuttingedgeinfo.com/msl-connection/.
  12. Сухова Т.Н. Взаимоотношения врачей и представителей фармацевтического бизнеса в современном обществе: Дис.. канд. мед. наук. М.; 2009.
  13. Решетников А.В. Методология исследований в социологии медицины: Руководство. М.: ММА им. И.М. Сеченова; 2000.
  14. Решетников А.В. Социология медицины (введение в научную дисциплину): Руководство. М.: Медицина; 2002.
  15. Решетников А.В. Технология социологического исследования как методическая основа медико-социологического мониторинга (часть I). Социология медицины. 2010; 1: 3-12.
  16. Решетников А.В. Медико-социальные системы: способы образования и сравнительный анализ. Социология медицины. 2005; 1: 3-17.
  17. Решетников А.В. Эволюция социологии медицины. Социология медицины. 2012; 2: 3-9.
  18. Ефименко С.А. Социологические теории и социология медицины о взаимодействии социальных субъектов. Социология медицины. 2005; 1: 17-22.
  19. Ефименко С.А., Зайцева Н.В. Управление персоналом в медицинских организациях: возможности социологического анализа. 2012; 2: 35-8.
  20. Толмачев А.В. Медицинский отдел: оптимизация деятельности. Ремедиум. 2012; 2: 55-7.
  21. Толмачев А.В., Фадус М., Гюлоян Э.Г. Непромоционная коммуникация в фармкомпании. Ремедиум. 2013; 10: 61-5.
  22. Толмачев А.В. Медицинский отдел: ключевые показатели эффективности. Ремедиум. 2013; 3: 51-4.

Copyright (c) 2014 Eco-Vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies